261 related articles for article (PubMed ID: 27936030)
1. Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts.
Kaul SC; Ishida Y; Tamura K; Wada T; Iitsuka T; Garg S; Kim M; Gao R; Nakai S; Okamoto Y; Terao K; Wadhwa R
PLoS One; 2016; 11(12):e0166945. PubMed ID: 27936030
[TBL] [Abstract][Full Text] [Related]
2. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
[TBL] [Abstract][Full Text] [Related]
3. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
4. Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.
Wang J; Zhang H; Kaul A; Li K; Priyandoko D; Kaul SC; Wadhwa R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680087
[No Abstract] [Full Text] [Related]
5. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
6. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
7. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
8. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
9. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
10. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
11. Distribution of withaferin A, an anticancer potential agent, in different parts of two varieties of Withania somnifera (L.) Dunal. grown in Sri Lanka.
Siriwardane AS; Dharmadasa RM; Samarasinghe K
Pak J Biol Sci; 2013 Feb; 16(3):141-4. PubMed ID: 24171276
[TBL] [Abstract][Full Text] [Related]
12. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
13. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
14. Quantitative HPLC analysis of withanolides in Withania somnifera.
Ganzera M; Choudhary MI; Khan IA
Fitoterapia; 2003 Feb; 74(1-2):68-76. PubMed ID: 12628397
[TBL] [Abstract][Full Text] [Related]
15. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
16. Traditional Horticulture Practices Increase the Production of Selected Withanolides in Withania Somnifera (L.) Dunal-A RP-UFLC Analysis.
Ankad GM; Pai SR; Hiremath J; Hegde HV
J Chromatogr Sci; 2020 Oct; 58(10):899-906. PubMed ID: 32880395
[TBL] [Abstract][Full Text] [Related]
17. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.
Widodo N; Priyandoko D; Shah N; Wadhwa R; Kaul SC
PLoS One; 2010 Oct; 5(10):e13536. PubMed ID: 20975835
[TBL] [Abstract][Full Text] [Related]
18. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection.
Chaurasiya ND; Uniyal GC; Lal P; Misra L; Sangwan NS; Tuli R; Sangwan RS
Phytochem Anal; 2008; 19(2):148-54. PubMed ID: 17879227
[TBL] [Abstract][Full Text] [Related]
19. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
20. Withania frutescens (L.) Pauquy, a valuable Mediterranean shrub containing bioactive withanolides.
Bouissane L; Bailly C
Steroids; 2024 Jul; 207():109439. PubMed ID: 38740121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]